IgA nephropathy: open trials in Canada

• NCT06963827

  A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

  Trial Treatment · Phase 3 · Takeda

  Sheldon M. Chumir Health Centre, Calgary · London Health Sciences Centre, London · Sunnybrook Health Sciences Centre, Toronto

  Registry updated 2026-11-04

• NCT06935357

  A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  Trial Treatment · Phase 3 · Biogen

  McGill University Health Centre (MUHC), Montreal · St. Paul's Hospital, Vancouver

  Registry updated 2026-10-14

• NCT04557462

  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Oshawa

  Registry updated 2026-10-05

• NCT06858319

  Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Toronto

  Registry updated 2026-08-17

All IgA nephropathy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error